Anterior STEMI Revealing Homozygous Familial Hypercholesterolemia With Supravalvular Aortic Stenosis Authors: Pramod Tulsidas Gitte, Milind Kharche, Umesh Khedkar, Deepak Borde, Anand Deodhar Published: 2026 ABSTRACT AbstractBackgroundHomozygous familial hypercholesterolemia (HoFH) causes markedly elevated low-density lipoprotein cholesterol from birth, accelerated atherosclerosis, and early cardiovascular death. Supravalvular aortic stenosis is an uncommon but serious cardiovascular manifestation.Case SummaryA 20-year-old Asian man presented with a 4-hour history of rest angina associated with diaphoresis and was diagnosed with an anterior ST-segment elevation myocardial infarction (STEMI). Lipid testing showed a total cholesterol level of 570 mg/dL and a low-density lipoprotein cholesterol level of 510 mg/dL, with an elevated lipoprotein(a) level of 176 nmol/L. Echocardiography demonstrated supravalvular flow acceleration across normal tricuspid aortic valve with a Doppler peak/mean gradient of 43/12 mm Hg. Computed tomography aortography showed focal sinotubular junction/ascending aortic narrowing with a planimetry area of 1.09 cm2. Coronary angiography showed left main and triple-vessel coronary artery disease. Whole-exome testing revealed a homozygous pathogenic LDLR variant in exon 11. He underwent coronary artery bypass grafting with supra-aortic patch aortoplasty.DiscussionThis case highlights genetically confirmed HoFH presenting as anterior ST-segment elevation myocardial infarction with surgically repaired supravalvular aortic stenosis at 20 years of age, emphasizing multimodality imaging, heart team planning, and lipid-lowering therapy.Take-Home MessageHoFH should be suspected in any very young patient with myocardial infarction, severe hypercholesterolemia, and a family history of dyslipidemia or sudden death.Key Words: coronary artery bypass grafting, homozygous familial hypercholesterolemia, LDLR, lipoprotein(a), ST-segment elevation myocardial infarction, supravalvular aortic stenosis History of Presentation A 20-year-old Asian man presented with a 4-hour history of severe rest angina associated with sweating. On admission, his pulse rate was 91 beats/min, blood pressure was 100/60 mm Hg, and oxygen saturation was 95% on room air. There were no tendon xanthomas, xanthelasma, or other stigmata of dyslipidemia on physical examination. Cardiovascular examination revealed a Levine grade III/VI systolic murmur at the right second intercostal space radiating to both carotids, consistent with supravalvular outflow turbulence despite a normal native aortic valve. The remainder of the systemic examination was unremarkable. Electrocardiography demonstrated acute anterior wall ST-segment elevation myocardial infarction (STEMI) (Figure 1A). Take-Home Messages •In any patient younger than 30 years presenting with myocardial infarction and low-density lipoprotein cholesterol level >400 mg/dL, HoFH should be considered urgently and confirmed genetically, whenever possible. In any patient younger than 30 years presenting with myocardial infarction and low-density lipoprotein cholesterol level >400 mg/dL, HoFH should be considered urgently and confirmed genetically, whenever possible. •Supravalvular aortic stenosis in HoFH may be clinically relevant even when the Doppler mean gradient is modest; therefore, multimodality imaging, including Doppler assessment and computed tomography planimetry, can be valuable for operative planning. Supravalvular aortic stenosis in HoFH may be clinically relevant even when the Doppler mean gradient is modest; therefore, multimodality imaging, including Doppler assessment and computed tomography planimetry, can be valuable for operative planning. Multimodality Imaging in Homozygous Familial Hypercholesterolemia (A) Electrocardiogram showing anterior ST-segment elevation. (B) Speckle-tracking echocardiogram demonstrating reduced global longitudinal strain with anterior wall involvement. (C) Pulse-wave Doppler showing supravalvular flow acceleration with a normal aortic valve. (D) Doppler across the ascending aorta showing increased velocity (∼3.2 m/s) and gradient (∼43 mm Hg). Past Medical History There was no previously documented cardiac illness. The family history was remarkable for sudden cardiac death in the patient's grandmother at 30 years of age. Both parents, paternal grandfather, elder brother, paternal aunt, and paternal uncle had significantly deranged lipid profiles, although none had a documented history of premature cardiovascular disease. This pattern strongly suggested an inherited lipid disorder with vertical transmission in the family (Figure 2). Pedigree in Homozygous Familial Hypercholesterolemia Three-generation pedigree showing familial dyslipidemia. The proband (arrow) has markedly elevated LDL-C levels and a homozygous LDLR mutation. The family history includes premature sudden cardiac death, consistent with inherited disease. ASCVD = atherosclerotic cardiovascular disease; CVD = cardiovascular disease; HoFH = homozygous familial hypercholesterolemia; LDL = low-density lipoprotein; LDL-C = low-density lipoprotein cholesterol; Lp(a) = lipoprotein(a); MI = myocardial infarction; SCD = sudden cardiac death; STEMI = ST-segment elevation myocardial infarction; TC = total cholesterol. Differential Diagnosis The differential diagnosis included premature atherosclerotic acute coronary syndrome due to inherited dyslipidemia, coronary vasculitis, congenital coronary anomalies, and thrombophilia-related coronary thrombosis. For the supravalvular lesion, syndromic and familial causes of supravalvular aortic stenosis (SVAS) were also considered, including Williams-Beuren syndrome and elastin-associated nonsyndromic SVAS; however, the patient had no phenotypic features suggestive of a syndromic disorder, and imaging localized the obstruction to the sinotubular junction/ascending aorta rather than the valve leaflets. The combination of profound hypercholesterolemia, family history, multivessel premature coronary artery disease (CAD), and genetic confirmation established homozygous familial hypercholesterolemia (HoFH) as the unifying diagnosis. Investigations Cardiac enzymes were elevated. Patient had a serum parathyroid hormone level of 57 pg/mL and a thyroid-stimulating hormone level of 2.8 mIU/L. The fasting lipid profile showed a total cholesterol level of 570 mg/dL, a triglyceride level of 116 mg/dL, a low-density lipoprotein cholesterol (LDL-C) level of 510 mg/dL, and a high-density lipoprotein cholesterol level of 31 mg/dL. The lipoprotein(a) (Lp(a)) level was elevated at 176 nmol/L (normal <75 nmol/L). Transthoracic echocardiography demonstrated moderate left ventricular systolic dysfunction with anterior wall hypokinesia and a left ventricular ejection fraction of 40% (Figure 1B, Video 1). A significant turbulent jet was seen in the ascending aorta above a well-functioning native tricuspid aortic valve, with a peak/mean Doppler gradient of 43/12 mm Hg supporting SVAS at the supravalvular level rather than primary valvular aortic stenosis (Figures 1C and 1D, Video 2). Coronary angiography showed 60% stenosis of the ostial and distal left main coronary artery, 80% stenosis in the proximal and mid–left anterior descending artery, 70% stenosis in the mid-dominant left circumflex artery, and 60% to 70% stenosis in the proximal nondominant right coronary artery (Video 3, Video 4, Video 5, Video 6). Computed tomography (CT) aortography demonstrated 45% to 50% luminal narrowing of the proximal ascending aorta beginning at the sinotubular junction and extending for 1.25 cm, with eccentric calcification, wall thickening, and a planimetry area of 1.09 cm2 (Figures 3A and 3B). Whole-exome sequencing confirmed a homozygous pathogenic variant in exon 11 of the LDLR gene on chromosome 19, consistent with genetically proven HoFH. Computed Tomography Aortogram Showing Supravalvular Aortic Stenosis (A) Computed tomography aortogram showing focal narrowing at the sinotubular junction (arrow). (B) Computed tomography planimetry area of 1.09 cm2 at the narrowest part of the ascending aorta (Ao). LC = left coronary cusp; LV = left ventricle; RC = right coronary Cusp; NC = non coronary cusp. Management The patient was initially treated with low-molecular-weight heparin, aspirin 75 mg once daily, ticagrelor 90 mg twice daily, atorvastatin 80 mg once daily, ezetimibe 10 mg once daily, bempedoic acid 180 mg once daily, bisoprolol 1.25 mg once daily, and ramipril 1.25 mg once daily. Given anterior STEMI with left main and multivessel CAD, together with a discrete supravalvular lesion identified on echocardiography and CT, the heart team favored single-stage surgical revascularization and aortic repair over a coronary-only strategy. He underwent successful coronary artery bypass grafting (CABG) using a LIMA-RIMA Y graft to the left anterior descending and obtuse marginal arteries along with supravalvular patch aortoplasty (Video 7). This approach allowed definitive management of complex coronary disease while correcting the focal ascending aortic narrowing during the same operation. Outcome and Follow-Up On postoperative day 5, echocardiography showed a reduced ascending aortic peak gradient of 15 mm Hg with persistent moderate left ventricular systolic dysfunction. He was counseled regarding the likely need for further LDL-C lowering with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-directed therapy or inclisiran. At 3-month follow-up, the patient remained clinically stable, although LDL-C was still markedly elevated at 249 mg/dL, despite atorvastatin 80 once daily, ezetimibe 10 once daily, and bempedoic acid 180 once daily. He therefore received the first dose of inclisiran and was advised serial lipid profile monitoring and long-term follow-up for recurrent coronary and aortic disease. Given the family history and genetic result, cascade screening of first-degree relatives was strongly indicated but was not performed because of financial constraints and unwillingness of family members. Discussion HoFH is most commonly caused by pathogenic variants in LDLR and is characterized by lifelong exposure to extreme LDL-C levels, rapidly progressive atherosclerosis, and premature cardiovascular events, often beginning in childhood or early adulthood.1,2 Historically, untreated patients frequently died before 30 years of age, although survival has improved with earlier diagnosis and more intensive lipid-lowering therapy.2,3 This case is notable for the simultaneous presence of anterior STEMI, left main triple-vessel CAD, and SVAS at 20 years of age. Although aortic valvular and supravalvular diseases are recognized complications of HoFH, SVAS is less common than coronary involvement and is associated with a worse prognosis.4,5 The lesion in our patient arose at the sinotubular junction with eccentric calcification, a pattern consistent with cholesterol-driven aortic root and supravalvular atherosclerotic disease described in HoFH.4,6 The supravalvular lesion in this patient was supported by multimodality imaging rather than by Doppler findings alone. Echocardiography demonstrated supravalvular flow acceleration above a normal tricuspid aortic valve, with a Doppler peak/mean gradient of 43/12 mm Hg, whereas CT showed focal sinotubular junction/proximal ascending aortic narrowing with eccentric calcification and a planimetry area of 1.09 cm2. Taken together, these findings support anatomically significant SVAS despite a modest mean gradient and help to explain why repair was performed at the time of CABG.4, 5, 6 A second important feature is the markedly elevated Lp(a) level. Elevated Lp(a) independently augments atherosclerotic risk in familial hypercholesterolemia and may further promote calcific disease involving the aortic root, valve, or supravalvular region.7 In this patient, the coexistence of extreme LDL-C elevation and elevated Lp(a) likely accelerated both coronary and aortic pathologies. The management strategy also deserves emphasis. Because HoFH may involve the coronary tree and proximal aorta simultaneously, treatment must address both structural disease and lifelong lipid burden. In our patient, CABG plus supravalvular patch aortoplasty provided definitive revascularization and correction of the focal supravalvular obstruction during the same operation while medical therapy was intensified postoperatively with maximally tolerated oral agents. Therapeutically, HoFH often responds incompletely to conventional oral lipid-lowering agents because efficacy depends partly on residual low-density lipoprotein (LDL) receptor activity.2,8 Although inclisiran is an attractive long-acting PCSK9-silencing therapy, the ORION-5 trial showed no significant overall LDL-C reduction in HoFH, with response appearing variable and likely dependent on genotype and residual LDLR function.9 Therefore, close post-treatment lipid monitoring is essential. In persistently uncontrolled disease, additional options such as LDL apheresis, lomitapide, evinacumab, or selected PCSK9 inhibitors should be considered where available and appropriate.2,8,9 This case also highlights the importance of genetic confirmation and family cascade screening. Genetic testing supports diagnostic certainty, informs prognosis, and can facilitate early identification of affected relatives before clinical events occur.1,7 In the present case, cascade screening was advised but limited by cost and family reluctance. Overall, the unique contribution of this report is the documentation of genetically confirmed HoFH presenting as anterior STEMI with concomitant surgically repaired SVAS in a 20-year-old adult. The case underscores the value of integrating echocardiography, CT, coronary angiography, genetic testing, and heart team decision making in young patients with severe inherited dyslipidemia and complex cardiovascular involvement.4,6,10 Conclusions This case illustrates an extreme cardiovascular phenotype of genetically confirmed HoFH due to a homozygous LDLR pathogenic variant, presenting as anterior STEMI, left main triple-vessel CAD, elevated Lp(a), and anatomically significant SVAS. Early recognition of severe inherited dyslipidemia in young patients with acute coronary syndrome is essential because timely diagnosis enables heart team planning, definitive revascularization, aortic repair, aggressive lipid lowering, and family cascade screening. Clinical Course, Genetic Diagnosis, and Surgical Management ACEi = angiotensin-converting enzyme inhibitor; BB = β-blocker; CABG = coronary artery bypass grafting; CT = computed tomography; DAPT = dual antiplatelet; ECG = electrocardiography; HoFH = homozygous familial hypercholesterolemia; LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery; LDL-C = low-density lipoprotein cholesterol; Lp(a) = lipoprotein(a); LV = left ventricular; LVEF = left ventricular ejection fraction; MI = myocardial infarction; prox = proximal; R 2nd ICS = right second intercostal space; RCA = right coronary artery; STEMI = ST-segment elevation myocardial infarction; SVAS = supravalvular aortic stenosis. Data Availability Statement All relevant data supporting the findings of this case are contained within the article. No additional data sets were generated or analyzed. In case the journal requires more data, it would be made available at request, if available with the authors. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Footnotes The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. Appendix For supplemental videos, please see the online version of this paper. Appendix Video 1 2D Echocardiography Showing Reduced LVEF With Anterior RWMA Video 2 LAO Caudal View Showing Significant Ostial LM, Ostial Ramus, and Ostioproximal LAD Lesion Video 3 Transesophageal Echocardiography Showing the Eccentric Narrowed Ascending Aorta With Color Turbulence at the Sinotubular Junction Video 4 TEE Showing the Ascending Aorta After Patch Aortoplasty Video 5 LAO Caudal View Video 6 PA Cranial View Showing Significant LAD Lesion Video 7 RAO Cranial View Showing Significant LM and LAD Lesions References Associated Data Supplementary Materials Video 1 2D Echocardiography Showing Reduced LVEF With Anterior RWMA Video 2 LAO Caudal View Showing Significant Ostial LM, Ostial Ramus, and Ostioproximal LAD Lesion Video 3 Transesophageal Echocardiography Showing the Eccentric Narrowed Ascending Aorta With Color Turbulence at the Sinotubular Junction Video 4 TEE Showing the Ascending Aorta After Patch Aortoplasty Video 5 LAO Caudal View Video 6 PA Cranial View Showing Significant LAD Lesion Video 7 RAO Cranial View Showing Significant LM and LAD Lesions Data Availability Statement All relevant data supporting the findings of this case are contained within the article. No additional data sets were generated or analyzed. In case the journal requires more data, it would be made available at request, if available with the authors.